Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis rats

Journal of Neuroscience Research

Volumn 67, Issue 2, 2002, Pages 191-199

  Van Der Laan, Luc J W ^a,b,c   Van Goes, Annette Der ^c,d,e   Wauben, Marca H M ^a   Ruuls, Sigrid R ^a,b   Dopp A ^a,b,c,d   De Groot, Corline J A ^a,b,c,e   Kuijpers, Taco W ^a,b,c   Elices, Mariano J ^a,d   Dijkstra, Christine D ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e CYTEL CORPORATION   (United States)

Author keywords

Astrocytes; BBB; CS1; Multiple sclerosis; VLA 4

Indexed keywords

ALPHA4 INTEGRIN; FIBRONECTIN; INTEGRIN ALPHA4 INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CELL ADHESION; CELL INFILTRATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM; EXTRACELLULAR MATRIX; IMMUNOREACTIVITY; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ASTROCYTES; BLOOD-BRAIN BARRIER; CELL ADHESION; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL DEATH; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS, LEUKOCYTE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4; LYMPHOCYTES; MACROPHAGES; MALE; PEPTIDES; RATS; RATS, INBRED LEW; RECEPTORS, IMMUNOLOGIC; STEM CELLS; T-LYMPHOCYTES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037080184     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10095     Document Type: Article

References (39)

1. Blockade of late-phase airway responses and airway hyper responsiveness in allergic sheep with a small-molecular peptide inhibitor of VLA-4
2. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma
3. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis
4. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells
5. Experimental allergic encephalomyelitis: Successful treatment in vivo with a monoclonal antibody that recognizes T helper cells
6. The adhesion molecule and cytokine profile of multiple sclerosis lesions
7. Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin
8. Interactions between lymphocytes, macrophages, and central nervous system cells
9. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1
10. Postmortem delay effects on neuroglial cells and brain macrophages from Lewis rats with acute experimental allergic encephalomyelitis: An immunohistochemical and cytochemical study
11. Lymphocyte adhesion to brain capillary endothelial cells in vitro
12. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis
13. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature
14. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
15. Lymphocyte adhesion and transendothelial migration in the central nervous system: The role of LFA-1, ICAM-1, VLA-4, and VCAM-1
16. Pathogenesis of inflammatory demyelination: Implications for therapy
17. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages
18. Tumor necrosis factor-α induces adhesion molecule expression on human fetal astrocytes
19. Integrins: Versatility, modulation, and signaling in cell adhesion
20. A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitis
21. Pathophysiological aspects of VLA-4 interactions and possibilities for therapeutical interventions
22. The pathophysiologic role of α4 integrins in vivo
23. Regulation of human T lymphocyte coactivation with an α4 integrin antagonist peptide
24. Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin α4β1
25. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
26. VCAM-1 is a CS1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelial
27. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts
28. Activation of NF-KB and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1
29. Transfer of experimental allergic encephalomyelitis in rats by means of lymph node cells
30. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines
31. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat
32. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis
33. Treatment of delay-type hypersensitivity with inhibitors of the VLA-4 integrin
34. Extracellular matrix proteins expressed by human adult astrocytes in vivo and in vitro: An astrocyte surface protein containing the CS1 domain contributes to binding of lymphoblasts
35. T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interaction
36. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment
37. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide
38. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin
39. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin